2024 Controlled & Modified Drug Release Summit
June 25-26, 2024
Hyatt Regency Princeton, Princeton, NJ
Main Conference Day One – Tuesday June 25, 2024
7:45am
9:00am
Collaboration is King! Ice Breaker
9:10am
9:15am
Selection of Modified Drug Release Technologies Based on API Preferences
Joseph Della Rocca, PhD
Associate Principal Scientist
Merck & Co.
9:50am
How To Accelerate Drug Product Optimization: Integrated Program Delivery Using Translational Pharmaceutics
Aruna Railkar, PhD
Senior Research Fellow
Quotient Sciences
10:25am
Percolation Behavior in an Immediate Release Tablet Dosage Form
Prajwal Thool, PhD
Scientist III, Synthetic Molecule Pharmaceutics
Genentech
10:50am
11:20am
Long-Acting Implant Product Development: Opportunities and Challenges
Seth Forster, PhD
Senior Scientist, Pharmaceutical Commercialization Technology
Merck & Co.
11:55am
PANEL DISCUSSION: Enhancing Bioavailability via Patient-Centric Formulation Approaches
12:40pm
2:00pm
The competences and Intricacies of Fluid Bed Technologies
Zafar Iqbal, PhD
Vice President & Head of Pharmaceutical Development
Glatt
2:35pm
The Impact of Excipient Selection on Modified Release Profiles
Kellyn Zagaja, PhD
Principal Scientist, Drug Product Design
Pfizer
3:10pm
Advances in Excipient Technologies to Drive Modified Release Oral Delivery
Jim Baxter, MS
North American Technical Business Development Manager, Pharmaceutical Excipients
Lubrizol
3:25pm
Afternoon Networking & Refreshment Break in Exhibit Hall
4:00pm
Spray Conjealing to Enhance Drug Product Bioavailability
Girish Nihalani, PhD
Research Fellow, Product Development
Teva Pharmaceuticals
4:35pm
Advancing Oral Based Modied Delivery for Rare Diseases via Lipid Based formulations
Vivek Gupta, PhD
Associate Professor, Pharmaceutical Sciences
St. John’s University
5:15pm-
6:30pm
Main Conference Day Two – Wednesday, June 26, 2024
8:00am
9:00am
9:10am
Predictive Power and Operational use of SCISSOR to Streamline SC Biologics Drug Development
Mikhail Murashov, PhD
Senior Scientist, Sterile and Specialty Products
Merck & Co.
9:45am
Using PBPK Modelling for Risk Assisessment in Drug Product Development
Siddharth S. Kesharwani, PhD
Biopharmaceutics Scientist
Sanofi
10:20am
Efficient New Tools for Solubility Enhancement and Lifecycle Management: Apisolex™ and Apinovex™ Polymers
Innovations in drug discovery and repurposing have generated renewed interest in small molecule development. While these efforts have grown the global project pipeline, many candidates suffer from solubility and bioavailability challenges. In order to formulate these complex molecules, new technologies and formulation approaches are needed to meet technical requirements while ensuring patient safety/compliance. Lubrizol Life Science’s injectable-grade Apisolex™ and oral-grade Apinovex™ polymers were designed to overcome poor solubility and unlock the future of small molecule drug delivery. Join us to learn about:
- Key considerations for novel solubility enhancement technologies
- New tools for solubility enhancement: Apinovex™ and Apisolex™ polymer technologies
- Case study data demonstrating solubility enhancement and high stable drug loading
- Safety/toxicity updates and future plans
- The importance of manufacturing and quality support for novel technologies
Nick DiFranco, B.S., MEM
Global Market Manager, Novel Pharmaceutical Excipients
Lubrizol Life Science
10:35am
Morning Networking & Refreshment Break
11:00am
High Concentration Dose Subcutaneous Delivery: Roadmap from Pre-Clinical to Launch
Indrajit Ghosh, PhD
Scientific Director, Biologics Product Development
Bristol Myers Squibb
11:30am
Leveraging Melt-Spray-Congeal Microspheres as a Versatile, Patient-centric Oral Multiparticulate Platform
Dipy Vasa, PhD
Principal Scientist, Drug Product Dev
Pfizer
11:55am
Strategies for ASD Formulation Development
Speaker TBC
Seran Biosciences
12:30pm
Networking Lunch
1:45pm
Cellular Model of the Oral Lymphatic Absorption Pathway
Ryan Pelis, PhD
Senior Principal Scientist, Pharmacokinetic Sciences
Novartis
2:20pm
Topical Ophthalmic Drug Delivery: Solubility & Permeability Considerations
Anand Uhbe, PhD
Senior Scientist, Sterile Liquids Product Development
Abbvie
2:55pm
Formulation of LAI: Understanding what Attributes Control Injectability
Kelly Zhang, PhD
Senior Scientist, Molecular and Biophysical Characterization
Merck
3:30pm
Chair’s Closing & 2024 Summit Concludes
Attend
Meet 120+ drug development professionals & learn over 2 YEARS worth of new product development strategies, formulation approaches, delivery technologies & regulatory updates while decreasing drug product time-to-market in just 3 days!
Sponsorship
Take advantage of the unique opportunity to engage your direct target audience face-to-face, and help them overcome their product challenges in 2 full interactive days!
Convince Your Boss
Want to attend but need help convincing your boss? Let us generate you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it: It’s up to you!